Managing Liver Injury (DILI) Risk
Having a clinical drug-induced liver injury (DILI) signal is a surefire way to kill a drug candidate in non-serious indications like pain or chronic indications like diabetes, and will even give oncologists second thoughts as cancer patients are living longer. What can we do to prevent it? A widely accepted strategy for minimizing DILI risk…
